Details for Patent: 5,854,290
✉ Email this page to a colleague
Summary for Patent: 5,854,290
Title: | Use of guanfacine in the treatment of behavioral disorders |
Abstract: | Disclosed is a method of treating disorders which have prominent symptoms of behavioral disinhibition (e.g., Attention-Deficit Hyperactivity Disorder, Conduct Disorder, Oppositional Defiant Disorder, Tourette's Syndrome, Lesch-Nyhan Syndrome, or the disinhibitory symptoms accompanying Post-traumatic Stress Disorder or dementia) in a primate with minimal sedative side effects by administering thereto a therapeutically effective amount of guanfacine. |
Inventor(s): | Arnsten; Amy F. T. (Bethany, CT), Goldman-Rakic; Patricia S. (New Haven, CT), Hunt; Robert H. (Nashville, TN) |
Assignee: | Arnsten; Amy F. T. (Bethany, CT) Goldman-Rakic; Patricia (New Haven, CT) Hunt; Robert H. (Nashville, TN) |
Application Number: | 08/531,643 |
Patent Claim Types: see list of patent claims | Use; | More… ↓ |
Drugs Protected by US Patent 5,854,290
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,854,290
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 6281298 | ⤷ Subscribe | |||
Israel | 129460 | ⤷ Subscribe | |||
Japan | 2001504811 | ⤷ Subscribe | |||
World Intellectual Property Organization (WIPO) | 9816226 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |